CES, LAS VEGAS, January 7, 2025 – QNX, a division of BlackBerry Limited (NYSE: BB; TSX:BB), Vector and TTTech Auto today ...
KLS-1 is under clinical development by Vector Vitale and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II drugs for Metastatic Melanoma have a 36% phase transition ...
Home > Pressemitteilung: HZI researchers develop RSV vaccine ... The technology based on the mouse cytomegalovirus promises long-lasting immune protection ...
Game-changing software, blockbuster partnerships, and a bold new vision are fueling BlackBerry's stunning stock rally.
TCA-101 is under clinical development by TCR Cure Biopharma Technology and currently in Phase II for Solid Tumor.
Spectre Divide is a competitive 3v3 tactical shooter driven by Duality, a mechanic that lets you control two bodies in real-time.
Veracode, a global leader in application risk management, today announced it has acquired certain assets of Phylum, Inc., ...
BlackBerry Limited BB recently announced strategic decisions focused on expanding its QNX division with innovation and advancements. QNX introduced a pioneer automotive software solution to streamline ...
Package Reputation is an essential capability for organizations seeking to secure their software supply chain. By analyzing ...
Cypris, a leading AI-powered research platform for R&D teams, is excited to announce the appointment of Chris Staymates as Chief Technology Officer (CTO), previously the Chief Innovation Officer at ...